Amer Zeidan: Can Early Blood Count Changes Predict Imetelstat Response in Lower Risk MDS?
Amer Zeidan, Chief, Division of Hematologic Malignancies; Professor of Medicine at Yale University, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Blood Cancer Journal, adding:
“Our newest paper on association between early neutropenia and thrombocytopenia with subsequent clinical response to imetelstat in lower risk MDS.”
Title: Association between treatment-emergent cytopenias and clinical responses to imetelstat in lower-risk myelodysplastic syndromes
Authors: Amer M. Zeidan, Valeria Santini, María Díez-Campelo, Michael R. Savona, Mikkael A. Sekeres, Yazan F. Madanat, Pierre Fenaux, Azra Raza, Moshe Mittelman, Sylvain Thépot, Rena Buckstein, Ulrich Germing, David Valcárcel, Anna Jonášová, Sheetal Shah, Qi Xia, Libo Sun, Shyamala Navada, Tymara Berry, Uwe Platzbecker and Rami S. Komrokji
Stay updated on all scientific advances Hemostasis Today.
-
Jun 5, 2026, 18:38Annie Bauzon: Clinical Significance and Causes of RBC Anisocytosis
-
Jun 5, 2026, 18:36Nandan Lad: Microclots as the Cause of Secondary Stroke After Subarachnoid Hemorrhage
-
Jun 5, 2026, 18:32George Sands: A Thoughtful Editorial on Low-Dose Rivaroxaban in Advanced CKD
-
Jun 5, 2026, 18:29Zain Khalpey: Recognizing High-Risk Coronary Hematoma Characteristics During PCI
-
Jun 5, 2026, 18:28Mirza Imail Baig: Silent but Significant – The Clinical Importance of Pulmonary Embolism
-
Jun 5, 2026, 17:26Anzila Waseem: Diet and Warfarin – A Guide to INR Stability
-
Jun 5, 2026, 17:06Lukas Mayer-Suess: How to Best Care for Patients Suffering Stroke Due to Isolated Cervical Internal Carotid Artery Occlusion
-
Jun 5, 2026, 17:02Sudhir Kumar: How Iron Deficiency Anemia Falsely Raises Diabetes Lab Results
-
Jun 5, 2026, 17:00Henning Nilius: An Explainable Machine Learning Tool for Pre-Surgery Screening